What is Carenostics?
Founded in 2021 and headquartered in Philadelphia, Pennsylvania, Carenostics operates as a chronic disease healthcare platform provider. The company aims to leverage technology to manage and improve outcomes for individuals with chronic conditions. Its focus on a critical area of healthcare positions it for significant impact and growth within the health tech sector.
How much funding has Carenostics raised?
Carenostics has raised a total of $5M across 1 funding round:
Angel/Seed
$5M
Angel/Seed (2023): $5M with participation from M13, GreatPoint Ventures, and Gaingels
Key Investors in Carenostics
M13
M13 is an early-stage venture capital firm focused on seed and Series A investments in visionary founders. The firm boasts a team of full-time operators dedicated to helping entrepreneurs scale their businesses efficiently and build category-defining software companies.
GreatPoint Ventures
GreatPoint Ventures is an early-stage venture capital firm located in San Francisco, California, founded by entrepreneurs and company-builders. The firm aims to support teams by providing funding, opening doors to customers, and recruiting experienced executives.
Gaingels
Gaingels is the leading investment syndicate in support of and representing the LGBTQ community and allies in the venture capital space. With over $380,000,000 deployed into a portfolio of over 600 companies since 2014, Gaingels is also the co-founder of Mathison.io.
What's next for Carenostics?
The recent major strategic investment indicates a strong validation of Carenostics' business model and market potential. This capital will likely be deployed to accelerate product development, expand market reach, and enhance its platform capabilities. The company is poised to scale its operations and further solidify its position in the competitive healthcare technology landscape, potentially moving towards broader enterprise-level adoption.
See full Carenostics company page
